Early and adequate correction of the anemic syndrome (AS) of
cancer patients can prevent deterioration in the quality of life and be considered as a reserve for increasing the effectiveness of treatment for
breast cancer (BC). The aim of the study was to assess the status of
iron using modern methods of ferrokinetics in
breast cancer patients on the background of
adjuvant chemotherapy for early diagnosis and adequate treatment of AS. The object of the study included 21
breast cancer patients with a relatively favorable prognosis, with
luminal types A and B (Her 2 / neu positive or negative), three times negative type. The examination was carried out in the postoperative period, against the background of
adjuvant chemotherapy. The main metabolites of ferrokinetics were studied:
hepcidin 25 (GP25);
ferritin (FR); soluble
transferrin receptors (rRTP); transferin (TRF);
iron (Fe);
erythropoietin (EPO); CRP and
IL-6 indicators. AC correction was performed (
ferinject, epotin-alpha, B12). 10 (47.6%) patients with
breast cancer had AS. Most of them were diagnosed with IDA with microcytic, hypochromic characteristics of erythrocytes, low concentration of FR, Fe, GP25,
IL-6, CRP, and high levels of TRP and rRTP. Functional
iron deficiency (FDF) was established in some patients. In contrast to patients with IDA, they had a high concentration of FR, CRP and significant production of GP25,
IL-6. The EPO level was not optimal for the majority of patients with AS. In isolated cases, during treatment with recombinant erythropoietins, a deficiency of
vitamin B12 (
cyanocobalamin) was revealed. The rational use of
iron preparations,
vitamins, and recombinant forms of EPO made it possible to restore Fe metabolism, stabilize the
hemoglobin level, and also improve the condition of most
breast cancer patients. The obtained data on
IL-6, GP25, CRP indicate a certain relationship between them in the development of
anemia with VDF in
breast cancer patients and the need for further study of the characteristics of
iron metabolism in
cancer patients.